Jubilant Pharmova reports significant increase in Q1 net profit to Rs 481.8 crore Ruchika Sharma23 July 2024 10:00 AM ISTNew Delhi: Jubilant Pharmova Ltd has announced a significant increase in its consolidated net profit to Rs 481.8 crore. The net profit...
USFDA classifies Jubilant Draximage Montreal facility as VAI Ruchika Sharma22 July 2024 11:30 AM ISTNoida: Jubilant Pharmova Limited's wholly owned subsidiary Jubilant Pharma Limited, has announced that its subsidiary Jubilant Draximage Inc....
USFDA concludes audit at Jubilant Generics Roorkee site Ruchika Sharma3 Feb 2024 1:30 PM ISTNoida: Jubilant Pharmova Limited announced that the United States Food and Drug Administration (USFDA) has concluded audit of the solid dosage...
USFDA classifies Jubilant Pharmova Nanjangud facility as Voluntary Action Indicated Ruchika Sharma9 March 2023 2:15 PM ISTNoida: Jubilant Pharmova Limited has announced that pursuant to the United States Food and Drug Administration (USFDA) inspection of its API...
Jubilant Draximage bags USFDA nod for Technetium Mertiatide Injection Ruchika Sharma1 Feb 2023 12:15 PM ISTNoida: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Draximage Inc has announced that it has received approval from the US Food...
Jubilant Pharmova gets 8 USFDA obervations for Nanjangud facility Ruchika Sharma15 Dec 2022 3:00 PM ISTNoida: Jubilant Pharmova Limited has recently announced that the United States Food and Drug Administration (USFDA) has issued eight observations...
Jubilant Generics Roorkee facility determined as official action indicated Ruchika Sharma31 Oct 2022 12:46 PM ISTNoida: Jubilant Pharmova Limited's wholly owned subsidiary Jubilant Pharma Limited, today announced that its subsidiary Jubilant Generics Limited...
Jubilant Pharmova Roorkee facility gets 6 USFDA observations Rahul Verma5 Aug 2022 4:12 PM ISTJubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid Dosage...
USFDA issues 6 observations for Jubilant Pharmova Roorkee facility Ruchika Sharma3 Aug 2022 12:15 PM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid...
USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from list of excepted products from import Ruchika Sharma14 July 2022 4:09 PM ISTPost this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Jubilant to double US injectable capacity at cost of Rs 1498 crore Ruchika Sharma31 May 2022 11:46 AM ISTThis agreement is in addition to the $92 million filling line expansion announced in November 2021, which will be commercially available by the end of...
Jubilant Pharmova net profit declines 3 percent to Rs 143 crore in Q2 Ruchika Sharma25 Oct 2021 1:01 PM ISTNew Delhi: Pharmaceuticals firm Jubilant Pharmova Ltd on Friday reported a 3 per cent decline in consolidated net profit from continuing operations at...
